| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | TWSE Exchange | TW0004105002 ISIN |
| Taiwan Country | - Employees | 26 Mar 2026 Last Dividend | 13 Aug 2014 Last Split | - IPO Date |
TTY Biopharm Company Limited is a versatile entity engaged in the development, production, and international distribution of pharmaceutical and chemical drugs. Established in 1960 and based in Taipei, Taiwan, the company has broadened its reach globally through a strategic amalgamation of subsidiaries. It navigates the pharmaceutical industry through various specialized units: Oncology Business Unit, Health Care Unit, Anti-infection Business Unit, Domestic Cardiovascular and Gastrointestinal Drugs Business Unit, China Medicine Business Unit, and Other segments. Besides its primary focus on pharmaceuticals, TTY Biopharm also ventures into functional foods, alongside import, export trading, and investment activities, thereby encapsulating a comprehensive approach to health and wellness.